written on 25.06.2014

A new excuse for pharma to avoid the Twitterverse, thanks to the FDA


Any brand managers eager to jump into Twitter as soon as the FDA gave the go-ahead? No such luck. Last week's social media guidance on risk disclosures may have cleared up some of the regulatory fog, but in this case, clarity isn't a positive.